Since its approval for the treatment of diabetes, it has caught the attention of scientists and clinicians alike, as it was noted that patients using this drug for diabetes management also lost weight
3 min read The GLP-1 landscape changed on 1 April 2026, when the FDA approved Eli Lilly's orforglipron under the brand name Foundayo as the first non-peptide, small-molecule GLP-1 receptor agonist (GLP-1RA) anywhere in the world
Flaxseed oil has been summarized to have antioxidant, anti-inflammatory, anti-obesity, and bone osteoporosis improvement actions (12)
- Moisturizing, firm, shiny, smooth skin
Neuroprotection and stroke recovery Emerging research suggests DSIP may have neuroprotective properties
Odor is subtler but diagnostic